Autopsy report · NCT02685267
Docetaxel/Prednisone Versus Docetaxel/Prednisone and Enzalutamide in Castration-Resistant Prostate Cancer
Cause of deathNo reason given
Life of this trial
- Ran for about 1 year 6 months before it stopped.
- 9 participants enrolled.
- Results were posted on the registry 3 years 7 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Prostate Cancer Clinical Trials Consortium
- Sponsor type
- University, hospital or other
- Conditions
- Prostate Cancer
- Interventions
- Docetaxel; Enzalutamide; Prednisone
- Participants
- 9
- Sites
- 5
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.